Text Size

Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication

Uusitalo H., Chen E., Pfeiffer N., Brignole-Baudouin F., Kaarniranta K., Leino M., Puska P., Palmgren E., Hamacher T., Hofmann G., Petzold G., Richter U., Riedel T., Winter M., Ropo A.


  • 2010
  • Acta Ophthalmologica
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Clinical development

  • Affiliations

    University of Tampere, Tampere University Hospital, Tampere, Finland; St Erik Eye Hospital, Stockholm, Sweden; Augenklinik der Joh.-Gutenberg- Universität Mainz, Mainz, Germany; Department of Toxicology, University Paris Descartes, University Paris 6, Paris, France; University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland; Kuopion Näkökeskus, Kuopio, Finland; Helsingin Lääkärikeskus, Helsinki, Finland; Nyköpings Lasarett, Nyköping, Sweden; Praxis Starnberg, Starnberg, Germany; Praxis Schweinfurt, Schweinfurt, Germany; Praxis Kulmbach, Kulmbach, Germany; Praxis Regensburg, Regensburg, Germany; Praxis Dresden, Dresden, Germany; Praxis Bremen, Bremen, Germany; Santen Oy, Tampere, Finland

Related Publications

Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats

Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.


A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.


Valproic Acid Application to Modify Post Surgical Fibrosis in a Model of Minimally Invasive Bleb Surgery

Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022